A thermostable, chromatographically purified Ebola nano-VLP vaccine.
about
Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions.Utilization of Capsules for Negative Staining of Viral Samples within Biocontainment.Recent advances in vaccine development against Ebola threat as bioweapon.Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus
P2860
A thermostable, chromatographically purified Ebola nano-VLP vaccine.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A thermostable, chromatographically purified Ebola nano-VLP vaccine.
@ast
A thermostable, chromatographically purified Ebola nano-VLP vaccine.
@en
type
label
A thermostable, chromatographically purified Ebola nano-VLP vaccine.
@ast
A thermostable, chromatographically purified Ebola nano-VLP vaccine.
@en
prefLabel
A thermostable, chromatographically purified Ebola nano-VLP vaccine.
@ast
A thermostable, chromatographically purified Ebola nano-VLP vaccine.
@en
P2093
P2860
P1476
A thermostable, chromatographically purified Ebola nano-VLP vaccine.
@en
P2093
Camenzind G Robinson
Jesse T Steffens
John H Carra
Karen A O Martins
Rowena D Schokman
P2860
P2888
P356
10.1186/S12967-015-0593-Y
P50
P577
2015-07-15T00:00:00Z
P5875
P6179
1046721160